1 Product identity
Ingredient risk
1 ingredient to use with caution

Anavar

BrandHi-Tech Pharmaceuticals→Other Combinations Tablet or Pill 12 ingredients 1 caution DSLD #10293
Net contents: 180 ct
Target: Adults and Children 4 years and above
DSLD entry: 2012-06-25
2 Ingredients (12)
IngredientGroupSafety
Proprietary Blend with Extend-Rx(TM) Technology——
Dextrose, AgglomeratedGlucose—
Microcrystalline CelluloseCellulose—
Hydroxypropyl CelluloseHydroxypropylcellulose—
Hydroxypropyl MethylcelluloseHypromellose—
Dicalcium PhosphateCalciumConditionally Safe
Sodium Starch GlycolateSodium Starch Glycolate—
StarchStarch—
Magnesium StearateMagnesium stearateUse with Caution
Stearic AcidStearic Acid—
PovidonePovidone—
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID10293
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-06-25
6 More from Hi-Tech Pharmaceuticals
View Hi-Tech Pharmaceuticals Safety Scorecard → 50 products
Allergy-RxAnavar-PCr Tropical Punch FlavorAttention LinkBulasteroneCaralluma Fimbriata 20:1 extract 500 mgCholedrene
7 Cite this page
Vancouver
Pkhakadze G. Anavar — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 19]. Available from: https://supplement.ge/products/anavar-10293/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network